These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Clinical Impact of Heparin Kinetics During Catheter Ablation of Atrial Fibrillation: Meta-Analysis and Meta-Regression. Briceno DF; Villablanca PA; Lupercio F; Kargoli F; Jagannath A; Londono A; Patel J; Otusanya O; Brevik J; Maraboto C; Berardi C; Krumerman A; Palma E; Kim SG; Natale A; DI Biase L J Cardiovasc Electrophysiol; 2016 Jun; 27(6):683-93. PubMed ID: 27004444 [TBL] [Abstract][Full Text] [Related]
47. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
48. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation. Wu S; Yang YM; Zhu J; Wan HB; Wang J; Zhang H; Shao XH Am J Cardiol; 2016 Mar; 117(6):926-34. PubMed ID: 26803384 [TBL] [Abstract][Full Text] [Related]
49. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration. Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192 [TBL] [Abstract][Full Text] [Related]
50. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study. Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959 [TBL] [Abstract][Full Text] [Related]
51. Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis. Barra S; Baran J; Narayanan K; Boveda S; Fynn S; Heck P; Grace A; Agarwal S; Primo J; Marijon E; ProvidĂȘncia R Int J Cardiol; 2018 Sep; 266():136-142. PubMed ID: 29887429 [TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis. Romero J; Gabr M; Patel K; Briceno D; Diaz JC; Alviz I; Trivedi C; Mohanty S; Polanco D; Della Rocca DG; Lakkireddy D; Natale A; Di Biase L Europace; 2021 Feb; 23(2):226-237. PubMed ID: 33324978 [TBL] [Abstract][Full Text] [Related]
53. Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study. Ando M; Inden Y; Yoshida Y; Sairaku A; Yanagisawa S; Suzuki H; Watanabe R; Takenaka M; Maeda M; Murohara T Heart Vessels; 2019 Sep; 34(9):1533-1541. PubMed ID: 30840130 [TBL] [Abstract][Full Text] [Related]
54. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study. Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541 [TBL] [Abstract][Full Text] [Related]
55. Protamine use in transcarotid artery revascularization is associated with lower risk of bleeding complications without higher risk of thromboembolic events. Liang P; Motaganahalli RL; Malas MB; Wang GJ; Eldrup-Jorgensen J; Cronenwett JL; Nolan BW; Kashyap VS; Schermerhorn ML J Vasc Surg; 2020 Dec; 72(6):2079-2087. PubMed ID: 32273225 [TBL] [Abstract][Full Text] [Related]
56. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients. Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785 [TBL] [Abstract][Full Text] [Related]
57. Clinical experience of uninterrupted oral anticoagulants during atrial fibrillation ablation in elderly patients: a comparison with non-elderly patients. Matsunaga-Lee Y; Egami Y; Yanagawa K; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Yano M; Yamato M; Shutta R; Sakata Y; Nishino M; Tanouchi J Heart Vessels; 2020 Oct; 35(10):1454-1462. PubMed ID: 32335715 [TBL] [Abstract][Full Text] [Related]
58. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis. Han Z; Wu X; Chen Z; Ji W; Liu X; Liu Y; Di W; Li X; Yu H; Zhang X; Xu B; Lan RF; Xu W BMC Cardiovasc Disord; 2019 Jun; 19(1):138. PubMed ID: 31182014 [TBL] [Abstract][Full Text] [Related]
59. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis. Proietti R; AlTurki A; Di Biase L; China P; Forleo G; Corrado A; Marras E; Natale A; Themistoclakis S J Cardiovasc Electrophysiol; 2019 Apr; 30(4):468-478. PubMed ID: 30575175 [TBL] [Abstract][Full Text] [Related]
60. Catheter ablation of atrial fibrillation with uninterrupted anticoagulation: a meta-analysis of six randomized controlled trials. Di Monaco A; Guida P; Vitulano N; Quadrini F; Troisi F; Langialonga T; Grimaldi M J Cardiovasc Med (Hagerstown); 2020 Jul; 21(7):483-490. PubMed ID: 32040031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]